Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition
出版年份 2015 全文链接
标题
Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition
作者
关键词
Crizotinib, ALK, MET, Alveolar rhabdomyosarcoma, G2/M arrest, IGF1R
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 34, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-10-06
DOI
10.1186/s13046-015-0228-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Resistance to multikinase inhibitor actions mediated by insulin like growth factor-1
- (2015) Catia Lippolis et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
- (2015) William H. Chappell et al. Oncotarget
- Molecular and Functional Characterizations of the Association and Interactions between Nucleophosmin-Anaplastic Lymphoma Kinase and Type I Insulin-Like Growth Factor Receptor
- (2015) Bin Shi et al. NEOPLASIA
- Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells
- (2014) Jing Liu et al. BIOCHEMICAL PHARMACOLOGY
- U.S. Food and Drug Administration Approval: Crizotinib for Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer That Is Anaplastic Lymphoma Kinase Positive
- (2014) S. M. Malik et al. CLINICAL CANCER RESEARCH
- Prospective screening for ALK: Clinical features and outcome according to ALK status
- (2014) Vincent Fallet et al. EUROPEAN JOURNAL OF CANCER
- IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion
- (2014) Suren Sarkissyan et al. PLoS One
- Depolarization Controls TRAIL-Sensitization and Tumor-Selective Killing of Cancer Cells: Crosstalk with ROS
- (2014) Yoshihiro Suzuki-Karasaki et al. Frontiers in Oncology
- Classification of Rhabdomyosarcoma and Its Molecular Basis
- (2013) David M. Parham et al. ADVANCES IN ANATOMIC PATHOLOGY
- High ALK mRNA expression has a negative prognostic significance in rhabdomyosarcoma
- (2013) P Bonvini et al. BRITISH JOURNAL OF CANCER
- ALK gene amplification is associated with poor prognosis in colorectal carcinoma
- (2013) P Bavi et al. BRITISH JOURNAL OF CANCER
- Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma
- (2013) Monika Katharina Guenther et al. CANCER LETTERS
- Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth In Vitro and In Vivo
- (2013) J. Renshaw et al. CLINICAL CANCER RESEARCH
- Mechanisms of impaired differentiation in rhabdomyosarcoma
- (2013) Charles Keller et al. FEBS Journal
- Dynamic and Nuclear Expression of PDGFR and IGF-1R in Alveolar Rhabdomyosarcoma
- (2013) M. I. Aslam et al. MOLECULAR CANCER RESEARCH
- Off-Target Effects of c-MET Inhibitors on Thyroid Cancer Cells
- (2013) Y. Zhou et al. MOLECULAR CANCER THERAPEUTICS
- Human Rhabdomyosarcoma Cell Lines for Rhabdomyosarcoma Research: Utility and Pitfalls
- (2013) Ashley R. P. Hinson et al. Frontiers in Oncology
- Gastrointestinal Adenocarcinomas of the Esophagus, Stomach, and Colon Exhibit Distinct Patterns of Genome Instability and Oncogenesis
- (2012) A. M. Dulak et al. CANCER RESEARCH
- The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches
- (2012) Antonella De Luca et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Head and Neck Sarcomas
- (2012) James Paul O'Neill et al. NEUROSURGERY CLINICS OF NORTH AMERICA
- Anaplastic lymphoma kinase (ALK): Structure, oncogenic activation, and pharmacological inhibition
- (2012) Robert Roskoski PHARMACOLOGICAL RESEARCH
- High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma
- (2011) J. H. Schulte et al. CLINICAL CANCER RESEARCH
- Anaplastic Lymphoma Kinase Aberrations in Rhabdomyosarcoma: Clinical and Prognostic Implications
- (2011) J. Carlijn van Gaal et al. JOURNAL OF CLINICAL ONCOLOGY
- An overview of the c-MET signaling pathway
- (2011) Shawna Leslie Organ et al. Therapeutic Advances in Medical Oncology
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- MET signalling: principles and functions in development, organ regeneration and cancer
- (2010) Livio Trusolino et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anaplastic lymphoma kinase: signalling in development and disease
- (2009) Ruth H. Palmer et al. BIOCHEMICAL JOURNAL
- IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells
- (2009) P. Shi et al. BLOOD
- PUMA- and Bax-induced autophagy contributes to apoptosis
- (2009) K S Yee et al. CELL DEATH AND DIFFERENTIATION
- Inhibition of Insulin-Like Growth Factor 1 Receptor by CP-751,871 Radiosensitizes Non-Small Cell Lung Cancer Cells
- (2009) T. Iwasa et al. CLINICAL CANCER RESEARCH
- Addiction to Elevated Insulin-like Growth Factor I Receptor and Initial Modulation of the AKT Pathway Define the Responsiveness of Rhabdomyosarcoma to the Targeting Antibody
- (2008) L. Cao et al. CANCER RESEARCH
- ALK Expression in Rhabdomyosarcomas: Correlation with Histologic Subtype and Fusion Status
- (2008) Diana A. Corao et al. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search